advanced search

INDUSTRIALISATION

DEVELOPING A FULLY AUTOMATED MODULAR MACHINE PLATFORM FOR AUTOINJECTOR TESTING
INDUSTRIALISATION
Lucy Chung
SHL Medical
DEVELOPING A FULLY AUTOMATED MODULAR MACHINE PLATFORM FOR AUTOINJECTOR TESTING
Lucy Chung and Gilbert Fluetsch discuss the benefits of a modular automated test platform.
ENHANCED PROCESS CONTROL FOR LIPID-BASED NANOPARTICLES: LNPS AND LIPOSOMES
EARLY INSIGHT
Dr Antonio Costa
ENHANCED PROCESS CONTROL FOR LIPID-BASED NANOPARTICLES: LNPS AND LIPOSOMES
Antonio Costa discusses the use of lipid nanoparticles in the modern drug delivery industry and introduces the DIANT system for the continuous processing of nanoparticles with integrated process analytical technology, which can provide the quality required for these injectable, complex formulations.
THE FUTURE OF CONTAINER-LEVEL TRACEABILITY FOR PREFILLABLE SYRINGES
INDUSTRIALISATION
Sam Eubanks
BD (Becton Dickinson & Company)
THE FUTURE OF CONTAINER-LEVEL TRACEABILITY FOR PREFILLABLE SYRINGES
Sam Eubanks and Hervé Soukiassian discuss the BD traceability solution. This concept under development aims to deliver traceability at the unique container level from manufacture to the point of care.
HOW DIGITISATION IS DELIVERING COMPETITIVE ADVANTAGE IN DEVICE ASSEMBLY
INDUSTRIALISATION
Jens Schou Christensen
Stevanato Group
HOW DIGITISATION IS DELIVERING COMPETITIVE ADVANTAGE IN DEVICE ASSEMBLY
Jens Schou Christensen and Sebastian Berninger-Lund present the business case for the wider implementation of digitisation and the greater use of data to deliver assembly line improvements.
PUTTING POST-PANDEMIC SUPPLY CHAINS TO THE TEST
INDUSTRIALISATION
John Swift
Owen Mumford
PUTTING POST-PANDEMIC SUPPLY CHAINS TO THE TEST
John Swift discusses the need for medtech companies to undertake a reappraisal of their supply chains in light of covid-19, taking into consideration how the pandemic has exposed vulnerabilities that have previously gone unnoticed or ignored.
INDUSTRIALISATION OF DRUG DELIVERY BEYOND MANUFACTURING
INDUSTRIALISATION
Napoleon Monroe
New Directions Technology Consulting
INDUSTRIALISATION OF DRUG DELIVERY BEYOND MANUFACTURING
Napoleon Monroe considers the impact of the changing technological landscape on how industrialisation in the healthcare industry is evolving, with reference to the idea of “patients as consumers” and how the relationship between consumers, information and industry has evolved in other sectors, such as tech and retail – and how big players in those sectors are looking to move into and disrupt healthcare.
UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
INDUSTRIALISATION
Hiroki Hasegawa
Mitsubishi Gas Chemical
UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
Hiroki Hasegawa and Tomohiro Suzuki discuss the advantages of OXYCAPT™ multilayer plastic vial and syringe, which combine the benefits of cyclo-olefin polymer with excellent oxygen and UV barrier properties. In particular, the authors focus on recent studies that highlight OXYCAPT’s very low levels of extractables.
THE FOURTH INDUSTRIAL REVOLUTION – ROBOTICS AND THE LABORATORY
INDUSTRIALISATION
Prof Marc Brown
MedPharm
THE FOURTH INDUSTRIAL REVOLUTION – ROBOTICS AND THE LABORATORY
Marc Brown and Jon Lenn look at MedPharm’s implementation of automated robotic systems in enhancing workflow and the company’s plans for the future implementation of robotics in formulation development.
AUTOMATED LIPID NANOPARTICLE PRODUCTION: FROM PROTOCOL DEVELOPMENT TO GMP MANUFACTURE
EXPERT VIEW
Richard Gray
AUTOMATED LIPID NANOPARTICLE PRODUCTION: FROM PROTOCOL DEVELOPMENT TO GMP MANUFACTURE
Richard Gray and Julia Rashba-Step discuss the benefits of automated lipid nanoparticle production.
OVERCOMING DEVELOPMENT OBSTACLES TO THE DELIVERY OF EFFECTIVE OCULAR THERAPY
EXPERT VIEW
Robert Lee
OVERCOMING DEVELOPMENT OBSTACLES TO THE DELIVERY OF EFFECTIVE OCULAR THERAPY
Robert Lee discusses the growth of the ocular drug delivery market, the challenges formulators face in developing novel ocular technologies, and the role contract development and manufacturing organisations have to play in this growing market segment.
PRODUCT SHOWCASE: Evonik’s newly launched EUDRACAP™ functional, ready-to-fill capsules
GI/ORAL
Evonik
PRODUCT SHOWCASE: Evonik’s newly launched EUDRACAP™ functional, ready-to-fill capsules
Evonik introduces EUDRACAP™, its newly launched platform of functional ready-to-fill HPMC capsules, which helps optimise release profile, protects sensitive active ingredients, and speeds time to market.
SPECIALTY LCP COMPOUNDS FOR ELECTRONICS INTEGRATION IN CONNECTED MEDICAL DEVICES
CONNECTIVITY
Dr Young Kim
Celanese
SPECIALTY LCP COMPOUNDS FOR ELECTRONICS INTEGRATION IN CONNECTED MEDICAL DEVICES
Young Kim, Don DeMello and Philip Wilson, discuss the benefits of recent advances in liquid crystal polymer for connected medical devices.
PRACTICAL INSIGHTS INTO LACTOSE-BASED DPI FORMULATIONS, WITH & WITHOUT MAGNESIUM STEARATE
RESPIRATORY
Harry Peters
DFE Pharma
PRACTICAL INSIGHTS INTO LACTOSE-BASED DPI FORMULATIONS, WITH & WITHOUT MAGNESIUM STEARATE
Partners DFE Pharma, Hosokawa Micron and Harro Höfliger describe their unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate, whose findings will give generic players a head-start in the development process so that they can tap into this rapidly growing market. The three companies announce that they will be presenting the key insights from their research to interested parties during a joint webinar on the June 30th, 2020.
FROM PROCESS TO PRODUCT: OPTIMISING PROCESS DEVELOPMENT STRATEGIES FOR VARIABLE DRUG-DEVICE REQUIREMENTS
INJECTION
Markus Goldinger
SHL Medical
FROM PROCESS TO PRODUCT: OPTIMISING PROCESS DEVELOPMENT STRATEGIES FOR VARIABLE DRUG-DEVICE REQUIREMENTS
Markus Goldinger and Erik Alexandersson discuss the benefits to process development provided by SHL’s fully in-house, vertically integrated model, and how those benefits are applied throughout the process from initial design work to final assembly of the drug delivery device and primary container.
HOW TO ENSURE THE FUTURE DEMAND FOR BIOLOGICS CAN STILL BE DELIVERED BY INJECTABLES
INJECTION
Anthony Vico
Stevanato Group
HOW TO ENSURE THE FUTURE DEMAND FOR BIOLOGICS CAN STILL BE DELIVERED BY INJECTABLES
Anthony Vico and Enrico Barichello discuss the demands that high-viscosity biologic formulations place on prefilled syringes, and how pharmaceutical companies can make the most of this growing market segment to deliver improved quality of life for patients.
THE ADDED VALUE OF A PLATFORM APPROACH: PEN INJECTOR CASE STUDY
INJECTION
Dr Radoslaw Romanczuk
Nemera
THE ADDED VALUE OF A PLATFORM APPROACH: PEN INJECTOR CASE STUDY
Radosław Romańczuk, Severine Duband and Audrey Chandra discuss the development of the company’s pen-injector platforms and how they are tailored to meet the customer’s needs.
COMPARATIVE EXTRACTABLE STUDIES FOR INJECTABLES AND MEDICAL DEVICES ALIGNED WITH USP <1663> AND ISO 10993 GUIDELINES
INJECTION
Dr Matthias Bicker
SCHOTT Pharma
COMPARATIVE EXTRACTABLE STUDIES FOR INJECTABLES AND MEDICAL DEVICES ALIGNED WITH USP <1663> AND ISO 10993 GUIDELINES
Matthias Bicker, Michael Müller, Marc Mittermüller, Daniel Haines and Uwe Rothhaar discuss the regulatory requirements that need to be considered when designing an extractables and leachables study for a drug product or medical device. To illustrate the subject further, the authors provide two example studies, each following a different set of regulatory guidelines.
STATE-OF-THE-ART SOLUTIONS FOR OPHTHALMIC STERILE DRUG PRODUCT MANUFACTURING
OCULAR
Rainer Glockler
ten23 health
STATE-OF-THE-ART SOLUTIONS FOR OPHTHALMIC STERILE DRUG PRODUCT MANUFACTURING
In the first in a series of two articles, Rainer Glöckler and Carole Delauney discuss how the company’s state-of-the-art filling line meets the requirements and complexities that are particular to ophthalmic drug product manufacturing. The second article, to be published in May, will explore partnerships between pharma, CDMOs and syringe manufacturers in more detail.
LINKING THE “D” & “M” IN CDMO
EXPERT VIEW
Mr John Ross
LINKING THE “D” & “M” IN CDMO
John Ross looks at the role of CDMOs in product development through to commercialisation and considers the benefits of consolidated “DM” models.
INTERVIEW WITH BENJAMIN DIETIKER, WEIDMANN MEDICAL TECHNOLOGY
INTERVIEW
Benjamin Dietiker
INTERVIEW WITH BENJAMIN DIETIKER, WEIDMANN MEDICAL TECHNOLOGY
Benjamin Dietiker, Weidmann Medical Technology, talks with ONdrugDelivery about how the company has successfully implemented a growth strategy by focusing on key areas, plans for expansion, the effect of covid-19 on the business, and how the company differentiates itself from larger competitors by focusing on quality and service.
STEVANATO & EITAN BRING NEXT-GENERATION WEARABLE DRUG DELIVERY SOLUTIONS TO MARKET
WEARABLES
Chiara Mussoi
Stevanato Group
STEVANATO & EITAN BRING NEXT-GENERATION WEARABLE DRUG DELIVERY SOLUTIONS TO MARKET
Chiara Mussoi, Riccardo Prete and Mindy Katz outline the benefits of collaboration when it comes to bringing wearable drug delivery solutions to market.
HOW TO KEEP THE GRANDFATHER DILEMMA FROM INTERRUPTING DRUG REDEVELOPMENT
INJECTION
Chris Rojewski
Pfizer CentreOne
HOW TO KEEP THE GRANDFATHER DILEMMA FROM INTERRUPTING DRUG REDEVELOPMENT
Chris Rojewski provides programme insights into approval pathways for the redevelopment of pharmaceutical compounds.
MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE
CONNECTIVITY
Mr Michael Kiely
Jabil Healthcare
MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE
Michael Kiely, Laura Marsden, Peter Stringer, and David Boyle discuss the design challenges at the electromechanical interface and encourage manufacturers to adopt a standardised approach for connecting medical devices to the cloud.
AN ADVANCED CUSTOMISABLE COMPREHENSIVE DPI CAPSULE PORTFOLIO OFFERING
PULMONARY
Frédérique Bordes-Picard
Lonza
AN ADVANCED CUSTOMISABLE COMPREHENSIVE DPI CAPSULE PORTFOLIO OFFERING
Frédérique Bordes-Picard and Julien Lamps discuss the factors driving development in the area of capsule-based dry powder inhalers, and how the company’s Capsugel® Zephyr™ portfolio offering is perfectly positioned to meet and exceed industry’s growing and evolving requirements.
Top